Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

2021 Updates on MRD in CLL: Chemoimmunotherapy vs. Targeted Approach; IGHV & TP53 Mutations

128 views
May 13, 2021
Comments 0
Login to view comments. Click here to Login